Literature DB >> 7497562

Propofol emulsion and bacterial contamination.

G J McHugh1, G M Roper.   

Abstract

Package insert information provided with propofol advises prompt administration following its drawing-up. This study has examined the delays which occur between drawing-up and administration of propofol in clinical practice and the incidence of bacterial contamination occurring under such conditions. Two hundred and fifty-four clinical uses of propofol were examined. Mean elapsed times (range) from drawing-up to induction were 28.8 min (1-172), and 11.6 min (1-65) from induction to culture inoculation. The delay to induction exceeded ten minutes in 68.5% of propofol uses. Sixteen cultures (6.3%) grew bacteria. Delay to induction was not associated with increased chances of bacterial growth in any of the samples. Increasing delay between induction and culture inoculation was associated with greater odds of bacterial growth, which is consistent with contamination occurring at or after induction. Whilst the manufacturers advise prompt administration, our findings show that when inadvertent delays occur, propofol remains bacteriologically safe to use under standard clinical conditions. Microbial contamination can occur at any stage, thus attention to asepsis remains important throughout the administration period.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7497562     DOI: 10.1007/BF03011181

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  13 in total

1.  Growth of microorganisms in soybean oil emulsion and clinical implications.

Authors:  M Deitel; M Fuksa; V M Kaminsky; V Vasic
Journal:  Int Surg       Date:  1979-04

2.  Propofol: can a single ampule be used for multiple patients?

Authors:  G J Downs; P R Haley; J B Parent
Journal:  Anesthesiology       Date:  1991-06       Impact factor: 7.892

3.  Contamination of injection ports on intravenous cannulae.

Authors:  E P Oberhammer
Journal:  Lancet       Date:  1980-11-08       Impact factor: 79.321

4.  Growth of micro-organisms in solutions of intravenous anaesthetic agents.

Authors:  C B Berry; T Gillespie; J Hood; N B Scott
Journal:  Anaesthesia       Date:  1993-01       Impact factor: 6.955

5.  The practice of anesthesiology and the package insert: decision-making regarding drug use in anesthesiology.

Authors:  P F White; M F Watcha
Journal:  Anesth Analg       Date:  1993-05       Impact factor: 5.108

6.  Severe sepsis after intravenous injection of contaminated propofol.

Authors:  B Veber; B Gachot; J P Bedos; M Wolff
Journal:  Anesthesiology       Date:  1994-03       Impact factor: 7.892

7.  Growth of Staphylococcus aureus in four intravenous anesthetics.

Authors:  M B Sosis; B Braverman
Journal:  Anesth Analg       Date:  1993-10       Impact factor: 5.108

8.  Microbial growth patterns in intravenous fat emulsions.

Authors:  D Keammerer; C G Mayhall; G O Hall; L J Pesko; R B Thomas
Journal:  Am J Hosp Pharm       Date:  1983-10

9.  Growth curves of Staphylococcus aureus, Candida albicans, and Moraxella osloensis in propofol and other media.

Authors:  M Tessler; A Dascal; S Gioseffini; M Miller; J Mendelson
Journal:  Can J Anaesth       Date:  1992-05       Impact factor: 5.063

10.  Microbial growth and endotoxin production in the intravenous anesthetic propofol.

Authors:  M J Arduino; L A Bland; S K McAllister; S M Aguero; M E Villarino; M M McNeil; W R Jarvis; M S Favero
Journal:  Infect Control Hosp Epidemiol       Date:  1991-09       Impact factor: 3.254

View more
  3 in total

Review 1.  The Role of GABA Receptor Agonists in Anesthesia and Sedation.

Authors:  Janette Brohan; Basavana G Goudra
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

2.  The effect of implementing an aseptic practice bundle for anaesthetists to reduce postoperative infections, the Anaesthetists Be Cleaner (ABC) study: protocol for a stepped wedge, cluster randomised, multi-site trial.

Authors:  Alan F Merry; Derryn A Gargiulo; Ian Bissett; David Cumin; Kerry English; Christopher Frampton; Richard Hamblin; Jacqueline Hannam; Matthew Moore; Papaarangi Reid; Sally Roberts; Elsa Taylor; Simon J Mitchell
Journal:  Trials       Date:  2019-06-10       Impact factor: 2.279

3.  Infectious Disease Risk Associated with Contaminated Propofol Anesthesia, 1989-2014(1).

Authors:  Andrés Zorrilla-Vaca; Jimmy J Arevalo; Kevin Escandón-Vargas; Daniel Soltanifar; Marek A Mirski
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.